|1.||Ho, Han Kiat: 1 article (12/2012)|
|2.||Lee, Chern Yih: 1 article (12/2012)|
|3.||Saha, Sudipta: 1 article (12/2012)|
|4.||Chan, Debra Shu Zhen: 1 article (12/2012)|
|5.||Yap, Chun Wei: 1 article (12/2012)|
|6.||Wong, Winnie: 1 article (12/2012)|
|7.||Chan, Eric Chun Yong: 1 article (12/2012)|
|8.||New, Lee Sun: 1 article (12/2012)|
|9.||Chui, Wai Keung: 1 article (12/2012)|
|10.||Campos-Buzzi, Fátima: 1 article (09/2004)|
01/25/1965 - "[SUCCINIMIDES AND PREDISPOSITION TO CONVULSIONS]."
08/01/1991 - "Primary (Phase I) screening of these compounds indicated that succinimides 4d and 4e, containing lipophilic (+ pi), electron-withdrawing (+ sigma) phenyl substituents, were the most effective in controlling seizures induced by maximal electroshock (MES) and subcutaneous pentylenetetrazol (scMet). "
02/01/1981 - "Several derivatives of (R,S)-2-amino-N-substituted succinimides were synthetized and evaluated in mice against seizures produced by electroshock and pentylenetetrazol. "
|2.||Absence Epilepsy (Absence Seizure)
08/01/1990 - "5. These results, which demonstrate that anticonvulsant, but not convulsant, succinimides block LTCC, provide additional support for the hypothesis that LTCC reduction is a mechanism of action of the anticonvulsant succinimides related to their effects in petit mal epilepsy."
06/01/1960 - "Treatment of petit mal epilepsy with the new succinimides: PM 680 and celontin. "
|4.||Melanoma (Melanoma, Malignant)
09/01/2004 - "We now show the effects of several related cyclic imides: maleimides (S2, S2.1, S2.2, S3), glutarimides (S4, S5, S6), 4-aminoantipyrine derivatives (L1, F1, AL1, F1.14, F1.2) and sulfonated succinimides (RO1, FA, FE, FD, MC, DMC) on isolated rat liver mitochondria, B16-F10 melanoma cell line, peritoneal macrophages and different bacterial streams. "